Ingrid Kockum

21.5k total citations
248 papers, 8.1k citations indexed

About

Ingrid Kockum is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Ingrid Kockum has authored 248 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Genetics, 85 papers in Immunology and 84 papers in Pathology and Forensic Medicine. Recurrent topics in Ingrid Kockum's work include Multiple Sclerosis Research Studies (72 papers), Diabetes and associated disorders (72 papers) and Pancreatic function and diabetes (51 papers). Ingrid Kockum is often cited by papers focused on Multiple Sclerosis Research Studies (72 papers), Diabetes and associated disorders (72 papers) and Pancreatic function and diabetes (51 papers). Ingrid Kockum collaborates with scholars based in Sweden, United States and Germany. Ingrid Kockum's co-authors include Tomas Olsson, Lars Alfredsson, Jan Hillert, Åke Lernmark, Fredrik Piehl, Mona Landin‐Olsson, Mohsen Khademi, Anna Karin Hedström, Carani B. Sanjeevi and Gisela Dahlquist and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Ingrid Kockum

244 papers receiving 8.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ingrid Kockum 2.5k 2.4k 2.2k 1.7k 1.3k 248 8.1k
Simon H. S. Pearce 1.7k 0.7× 1.2k 0.5× 2.5k 1.1× 1.0k 0.6× 2.8k 2.1× 194 11.6k
Anthony P. Weetman 1.6k 0.6× 3.5k 1.5× 2.5k 1.1× 630 0.4× 1.6k 1.2× 218 11.2k
Shigenobu Nagataki 1.0k 0.4× 2.3k 1.0× 1.8k 0.8× 1.7k 1.0× 2.9k 2.2× 548 12.1k
Mario Rotondi 884 0.4× 1.4k 0.6× 861 0.4× 1.0k 0.6× 1.7k 1.3× 274 9.1k
Terry J. Smith 8.1k 3.2× 1.7k 0.7× 1.9k 0.9× 863 0.5× 3.0k 2.3× 284 15.1k
Terry F. Davies 1.3k 0.5× 2.7k 1.1× 3.7k 1.7× 1.1k 0.7× 3.3k 2.5× 349 13.4k
Petros Perros 2.7k 1.1× 522 0.2× 1.3k 0.6× 1.4k 0.8× 677 0.5× 170 7.7k
Wilhelm Kriz 1.5k 0.6× 1.3k 0.5× 2.9k 1.3× 2.1k 1.3× 8.5k 6.5× 240 19.6k
Jack P.M. Cleutjens 727 0.3× 1.5k 0.6× 574 0.3× 2.2k 1.4× 3.7k 2.8× 144 11.4k
Paolo Beck‐Peccoz 1.3k 0.5× 466 0.2× 1.9k 0.9× 2.4k 1.4× 2.6k 2.0× 239 12.0k

Countries citing papers authored by Ingrid Kockum

Since Specialization
Citations

This map shows the geographic impact of Ingrid Kockum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Kockum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Kockum more than expected).

Fields of papers citing papers by Ingrid Kockum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Kockum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Kockum. The network helps show where Ingrid Kockum may publish in the future.

Co-authorship network of co-authors of Ingrid Kockum

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Kockum. A scholar is included among the top collaborators of Ingrid Kockum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Kockum. Ingrid Kockum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sattarnezhad, Neda, Ingrid Kockum, Yicong Liu, et al.. (2025). Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls. Proceedings of the National Academy of Sciences. 122(11). e2424986122–e2424986122. 8 indexed citations
2.
Manouchehrinia, Ali, Hong Quach, Diana Quach, et al.. (2024). Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans. Proceedings of the National Academy of Sciences. 121(8). e2302259121–e2302259121. 4 indexed citations
3.
Hellberg, Sandra, Johanna Raffetseder, Mohsen Khademi, et al.. (2023). Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis. Nature Communications. 14(1). 6903–6903. 42 indexed citations
4.
Gustafsson, Rasmus, Katharina Fink, Anders Svenningsson, et al.. (2023). Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay. Frontiers in Immunology. 14. 1241199–1241199. 2 indexed citations
5.
6.
Biström, Martin, Jonatan Salzer, Pernilla Stridh, et al.. (2023). Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis. Brain. 147(1). 177–185. 13 indexed citations
7.
Rabenstein, Monika, Mohsen Khademi, Clas Malmeström, et al.. (2023). The impact of hybrid immunity on immune responses after SARS‐CoV‐2 vaccination in persons with multiple sclerosis treated with disease‐modifying therapies. European Journal of Neurology. 30(12). 3789–3798. 2 indexed citations
8.
Xavier, Alexandre, Vicki E. Maltby, Ewoud Ewing, et al.. (2023). DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes. International Journal of Molecular Sciences. 24(16). 12576–12576. 7 indexed citations
9.
Piehl, Fredrik, Tomas Olsson, Lars Alfredsson, et al.. (2022). Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort study. Journal of Neurology Neurosurgery & Psychiatry. 94(5). 337–348. 4 indexed citations
10.
Zheleznyakova, Galina Yurevna, Eliane Piket, Maria Needhamsen, et al.. (2021). Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology. Proceedings of the National Academy of Sciences. 118(17). 22 indexed citations
11.
Stridh, Pernilla, Jesse Huang, AK Hedström, et al.. (2021). Season of birth is associated with multiple sclerosis and disease severity. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(4). 3080428930–3080428930. 3 indexed citations
12.
Skelton, Alasdair, Nina Kirchner, & Ingrid Kockum. (2020). Skewness of Temperature Data Implies an Abrupt Change in the Climate System Between 1985 and 1991. Geophysical Research Letters. 47(23). 4 indexed citations
13.
Wu, Sean L., Xiaorong Shao, Patrick T. Bradshaw, et al.. (2020). Pregnancy does not modify the risk of MS in genetically susceptible women. Neurology Neuroimmunology & Neuroinflammation. 7(6). 3 indexed citations
14.
Carlström, Karl E., Ewoud Ewing, Mathias Granqvist, et al.. (2019). Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes. Nature Communications. 10(1). 3081–3081. 107 indexed citations
15.
Morikawa, Hiromasa, Ewoud Ewing, Stephan Ruhrmann, et al.. (2019). Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients. Scientific Reports. 9(1). 11996–11996. 11 indexed citations
16.
Guerreiro‐Cacais, André Ortlieb, Sahl Khalid Bedri, Mathias Linnerbauer, et al.. (2019). IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis. The Journal of Immunology. 203(4). 888–898. 16 indexed citations
17.
Darlington, Pernilla, Leif Tallstedt, Leonid Padyukov, et al.. (2011). HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis. European Respiratory Journal. 38(5). 1151–1157. 49 indexed citations
18.
Ramagopalan, S V, Jenny Link, Jake Byrnes, et al.. (2009). HLA-DRB1 and month of birth in multiple sclerosis. Neurology. 73(24). 2107–2111. 38 indexed citations
19.
Oak, Shilpa, Lisa K. Gilliam, Mona Landin‐Olsson, et al.. (2008). The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proceedings of the National Academy of Sciences. 105(14). 5471–5476. 58 indexed citations
20.
Kockum, Ingrid, Ralf Waßmuth, Eva Holmberg, B Michelsen, & Åke Lernmark. (1994). Inheritance of MHC class II genes in IDDM studied in population-based affected and control families. Diabetologia. 37(11). 1105–1112. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon H. S. Pearce Breakdown of academic impact, for papers by Anthony P. Weetman Breakdown of academic impact, for papers by Shigenobu Nagataki Breakdown of academic impact, for papers by Mario Rotondi Breakdown of academic impact, for papers by Terry J. Smith Breakdown of academic impact, for papers by Terry F. Davies Breakdown of academic impact, for papers by Petros Perros Breakdown of academic impact, for papers by Wilhelm Kriz Breakdown of academic impact, for papers by Jack P.M. Cleutjens Breakdown of academic impact, for papers by Paolo Beck‐Peccoz
Rankless by CCL
2026